News Daily News Dreams Dashed: Intravascular Therapy for MS Flops in Sham-Controlled Trial L.A. McKeown December 05, 2017
News Features Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate Michael O'Riordan November 27, 2017
News Conference News AHA 2017 Reimbursement Remedy Backfires: Stress Tests Have Shifted From Private Practice to Hospitals, Driving Up Costs Yael L. Maxwell November 16, 2017
News Conference News AHA 2017 Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear Todd Neale November 14, 2017
News Conference News TCT 2017 ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure Michael O'Riordan November 02, 2017
News Conference News TCT 2017 TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More Shelley Wood October 20, 2017
News Daily News Same-Day Discharge After PAD Procedures Safe in Elderly Patients L.A. McKeown October 09, 2017
News Conference News ESC 2017 CHANGE DAPT: Study Contests Benefit of Ticagrelor Over Clopidogrel After PCI in ACS Todd Neale August 30, 2017
News Features Stents as Essential Medicine: India’s Cap on Stent Prices Could Have Ripples Around the Globe Shelley Wood May 05, 2017